Clinical trials
Completed Lymphoma, Large B-Cell, Diffuse trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
861 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 49 |
| 2001 | 20 |
| 2002 | 34 |
| 2003 | 38 |
| 2004 | 39 |
| 2005 | 39 |
| 2006 | 34 |
| 2007 | 47 |
| 2008 | 33 |
| 2009 | 30 |
| 2010 | 29 |
| 2011 | 36 |
| 2012 | 26 |
| 2013 | 28 |
| 2014 | 19 |
| 2015 | 23 |
| 2016 | 28 |
| 2017 | 34 |
| 2018 | 35 |
| 2019 | 20 |
| 2020 | 29 |
| 2021 | 23 |
| 2022 | 15 |
| 2023 | 7 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 861 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 83 |
| Fred Hutchinson Cancer Center | 52 |
| Memorial Sloan Kettering Cancer Center | 31 |
| Case Comprehensive Cancer Center | 22 |
| Mayo Clinic | 18 |
| M.D. Anderson Cancer Center | 16 |
| Novartis Pharmaceuticals | 16 |
| City of Hope Medical Center | 15 |
| Hoffmann-La Roche | 14 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 14 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Large B-Cell, Diffuse | 861 |
| Lymphoma, Follicular | 463 |
| Lymphoma, Non-Hodgkin | 447 |
| Lymphoma, Mantle-Cell | 434 |
| Lymphoma | 413 |
| Burkitt Lymphoma | 389 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 376 |
| Lymphoma, B-Cell, Marginal Zone | 361 |
| Lymphoma, Large-Cell, Immunoblastic | 356 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 344 |
Trials
Showing 1 to 25 of 861. Each trial links to its page on Pharma Observatory.
761 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.